Organon (OGN) Receivables - Other (2020 - 2023)
Organon (OGN) posted quarterly Receivables - Other of $344.0 million for Q1 2023, down 3.91% year-over-year from $358.0 million in Q1 2022, and down 8.02% on a QoQ basis from $374.0 million in Q4 2022.
Organon (OGN) Receivables - Other (2020 - 2023) Analysis & Trends
Organon (OGN) has reported Receivables - Other for 4 consecutive years, with $344.0 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Receivables - Other fell 3.91% year-over-year to $344.0 million; the TTM figure through Mar 2023 stood at $344.0 million (down 3.91% YoY), while the FY2022 annual figure was $374.0 million, down 7.2% from the prior year.
- Receivables - Other came in at $344.0 million for Q1 2023 at Organon, down from $374.0 million in the prior quarter.
- The five-year high for Receivables - Other was $991.0 million in Q2 2021, with the low at $189.0 million in Q4 2020.
- Average Receivables - Other over 4 years is $491.0 million, with a median of $403.0 million recorded in 2021.
- Across the five-year window, Receivables - Other jumped 113.23% in 2021 and sank 56.21% in 2022, its largest moves.
- Year by year, Receivables - Other stood at $189.0 million in 2020, then soared by 113.23% to $403.0 million in 2021, then fell by 7.2% to $374.0 million in 2022, then slipped by 8.02% to $344.0 million in 2023.
- According to Business Quant data, Receivables - Other over the past three periods registered $344.0 million, $374.0 million, and $412.0 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 344.00 Mn |
| Mar 31, 2023 | 344.00 Mn |
| Dec 31, 2022 | 374.00 Mn |
| Dec 31, 2022 | 374.00 Mn |
| Sep 30, 2022 | 412.00 Mn |
| Sep 30, 2022 | 412.00 Mn |
| Jun 30, 2022 | 434.00 Mn |
| Jun 30, 2022 | 434.00 Mn |
| Mar 31, 2022 | 358.00 Mn |
| Mar 31, 2022 | 358.00 Mn |
| Dec 31, 2021 | 403.00 Mn |
| Dec 31, 2021 | 403.00 Mn |
| Sep 30, 2021 | 914.00 Mn |
| Sep 30, 2021 | 914.00 Mn |
| Jun 30, 2021 | 991.00 Mn |
| Jun 30, 2021 | 991.00 Mn |
| Dec 31, 2020 | 189.00 Mn |
| Dec 31, 2020 | 189.00 Mn |